Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Darren N. Seril"'
Autor:
Avantika Mishra, Darren N. Seril
Publikováno v:
Case Reports in Gastroenterology, Vol 12, Iss 2, Pp 521-527 (2018)
Biological agents are frequently used in the management of inflammatory bowel disease, and it is important to understand the potential adverse effects of these therapies. Ustekinumab is a human monoclonal antibody that interferes with interleukin-12
Externí odkaz:
https://doaj.org/article/1bb9a5cccab144b9bafe9a4690ec09ac
Autor:
Abhishek Bhurwal, Hemant R. Mutneja, Marcella Pimpinelli, Sophia Pimpinelli, Akshay Goel, Lea Ann Chen, Darren N. Seril
Publikováno v:
Gastroenterology. 162:S-420
Publikováno v:
Gastroenterology. 162:S-957
Autor:
Abhishek Bhurwal, Hemant R. Mutneja, Akshay Goel, Sophia Pimpinelli, Marcella Pimpinelli, Lea Ann Chen, Darren N. Seril
Publikováno v:
Gastroenterology. 162:S-67
Publikováno v:
Gastroenterology. 162:S-634
Publikováno v:
Gastroenterology. 162:S-636
Autor:
Darren N. Seril, Avantika Mishra
Publikováno v:
Case Reports in Gastroenterology, Vol 12, Iss 2, Pp 521-527 (2018)
Case Reports in Gastroenterology
Case Reports in Gastroenterology
Biological agents are frequently used in the management of inflammatory bowel disease, and it is important to understand the potential adverse effects of these therapies. Ustekinumab is a human monoclonal antibody that interferes with interleukin-12
Publikováno v:
American Journal of Gastroenterology. 114:S391-S393
Publikováno v:
Gastroenterology. 160:S-237
Publikováno v:
Inflammatory bowel diseases. 26(12)
BackgroundThe prevalence and clinical features of inflammatory bowel disease (IBD) vary among different racial and ethnic groups. The aim of this study was to compare the clinical and phenotypic features of Crohn’s disease (CD) and ulcerative colit